Stock listing
Gt Biopharma, Inc.
Selected listing: OXIA · SWB · EUR · DE
Gt Biopharma, Inc. (Stuttgart:OXIA), Health Technology. Latest release Sep 15, 2026: GT Biopharma Announces Potential New Indication for GTB-5550…
- Ticker
- Stuttgart:OXIA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Stuttgart
- Currency
- EUR
Latest news from Gt Biopharma, Inc.
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
September 15, 2026
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
September 11, 2026
GT Biopharma Reports Second Quarter 2026 Financial Results
August 14, 2026
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
June 7, 2026
GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives
June 1, 2026
Events
Replays
GT Biopharma, Inc. (GTBP) Q2 2021 Earnings Call
Fri, Aug 13, 2021 · 08:30 AM ET
Watch
Research Gt Biopharma, Inc.
Alternate listings
GTBP:NASDAQ
US · USD
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is OXIA:SWB.
GTBP:BOATS
US · USD
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is OXIA:SWB.
OXIA:GETTEX
DE · EUR
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is OXIA:SWB.
OXIA:MUN
DE · EUR
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is OXIA:SWB.
OXIA:FWB
DE · EUR
Alternate listing for Gt Biopharma, Inc.; the primary context on this page is OXIA:SWB.